Activity of combinations of ceftazidime, imipenem and pefloxacin against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa

被引：1
|
作者：
El-Sukhon, SN [1 ]
Boukhatem, ZF [1 ]
机构：
[1] Jordan Univ Sci & Technol, Fac Vet Med, Irbid, Jordan
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2003年 / 22卷 / 06期
关键词：
antibiotic combination; imipenem; ceftazidime; pelloxacin; chequerboard; fractional inhibitory concentration;
D O I：
10.1016/S0924-8579(03)00127-4
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
The chequerboard technique was used to look for synergistic combinations of ceftazidime, imipenem and pefloxacin. The synergistic combinations were used in vivo in mice experimentally infected with Escherichia coli, Salmonella typhimurium and Pseudomonas aeruginosa. In vitro ceftazidime/imipenem, ceftazidime/pefloxacin and pefloxacin/imipenem combinations showed synergistic effects against Staphylococcus aureus and S. typhimurium and additive effects against P. aeruginosa. Only the ceftazidime/pefloxacin combination was synergistic against E coli while the ceftazidime/imipenem and pefloxacin/imipenem combinations resulted in additive effects. In vivo, combination of ceftazidime/imipenem against E coli infection and the pefloxacin/imipenem combination against S. typhimurium infection were protective. (C) 2003 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码：613 / 617
页数：5
相关论文
共 50 条
  • [21] BACTERICIDAL ACTIVITY OF PEFLOXACIN COMPARED WITH 10 OTHER ANTIBIOTICS ON STAPHYLOCOCCUS-AUREUS AND PSEUDOMONAS-AERUGINOSA
    BOUANCHAUD, DH
    ROLIN, O
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1984, 10 (10) : 669 - 676
  • [22] Blue Laser Inhibits Bacterial Growth of Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa
    Alves de Sousa, Natanael Teixeira
    Santos, Marcos Ferracioli
    Gomes, Rosana Caetano
    Brandino, Hugo Evangelista
    Martinez, Roberto
    de Jesus Guirro, Rinaldo Roberto
    PHOTOMEDICINE AND LASER SURGERY, 2015, 33 (05) : 278 - 282
  • [23] QUINOLONE ACCUMULATION IN ESCHERICHIA-COLI, PSEUDOMONAS-AERUGINOSA, AND STAPHYLOCOCCUS-AUREUS
    MCCAFFREY, C
    BERTASSO, A
    PACE, J
    GEORGOPAPADAKOU, NH
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (08) : 1601 - 1605
  • [24] INHIBITION OF PSEUDOMONAS AERUGINOSA BY STAPHYLOCOCCUS AUREUS-ESCHERICHIA COLI CO-CULTURE
    Phelan, V
    PEDIATRIC PULMONOLOGY, 2015, 50 : 304 - 304
  • [25] Antibiotic Activity of Escherichia coli against Multiresistant Staphylococcus aureus
    Fais, T.
    Cougnoux, A.
    Dalmasso, G.
    Laurent, F.
    Delmas, J.
    Bonnet, R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (11) : 6986 - 6988
  • [26] Antibacterial activity of polyeugenol against staphylococcus aureus and escherichia coli
    Handayani, D. S.
    Pranoto
    Saputra, D. A.
    Marliyana, S. D.
    INTERNATIONAL CONFERENCE ON ADVANCED MATERIALS FOR BETTER FUTURE 2018, 2019, 578
  • [27] The evaluation of antimicrobial activity of zinc oxide nanoparticles on Candida albicans, Pseudomonas aeruginosa, Escherichia coli and Staphylococcus aureus
    Haghighi, F.
    Mohammadi, S. Roudbar
    Eskandari, M.
    Sadaat, M.
    MYCOSES, 2011, 54 : 62 - 62
  • [28] INVITRO ACTIVITY OF AZTREONAM, CEFOTAXIME, CEFTAZIDIME AND IMIPENEM COMBINED WITH CIPROFLOXACIN AGAINST GRAM-NEGATIVE BACILLI AND COMPARED WITH AMIKACIN COMBINATIONS AGAINST PSEUDOMONAS-AERUGINOSA
    ENCISO, MD
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (02) : 90 - 92
  • [29] Stability and antibacterial potency of ceftazidime and vancomycin eyedrops reconstituted in BSS® against Pseudomonas aeruginosa and Staphylococcus aureus
    Karampatakis, Vasileios
    Papanikolaou, Theoharis
    Giannousis, Michael
    Goulas, Antonis
    Mandraveli, Kaliopi
    Kilmpasani, Maria
    Alexiou-Daniel, Stella
    Mirtsou-Fidani, Vassiliki
    ACTA OPHTHALMOLOGICA, 2009, 87 (05) : 555 - 558
  • [30] Comparative antibacterial study between bioactive glasses and vancomycin hydrochloride against Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa
    Maany, Dina A.
    Alrashidy, Zainab M.
    Ghany, Nabil A. Abdel
    Abdel-Fattah, Wafa, I
    EGYPTIAN PHARMACEUTICAL JOURNAL, 2019, 18 (04) : 304 - 310
12345